Insider Stock Trading History of Ball F Michael


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ball F Michael since year 2005. The trader's CIK number is 1016350. At the time of this reporting, Ball F Michael is the Chief Executive Officer of Hospira Inc . (stock ticker symbol HSP). See this page for all insider trading activities at Hospira Inc .

Note that in the past Ball F Michael also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Ball F Michael since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-09-03 HSP Hospira Inc Option Ex 937,545 39.53 37,063,028
2011-01-11 STEC Simpletech Inc Option Ex 50,000 3.67 183,500
2011-01-11 STEC Simpletech Inc Sale 50,000 21.03 1,051,500
2011-01-03 STEC Simpletech Inc Option Ex 10,000 2.74 27,400
2011-01-03 STEC Simpletech Inc Sale 10,000 19.00 190,000
2010-11-03 AGN Allergan Inc Sale 304,200 73.00 22,206,600
2010-11-03 AGN Allergan Inc Option Ex 314,200 36.92 11,599,949
2010-05-28 STEC Simpletech Inc Option Ex 30,000 8.12 243,750
2010-05-28 STEC Simpletech Inc Sale 30,000 12.02 360,690
2007-08-03 AGN Allergan Inc Option Ex 67,470 40.08 2,704,197
2007-08-03 AGN Allergan Inc Sale 67,470 65.00 4,385,550
2007-07-02 AGN Allergan Inc Option Ex 20,106 53.13 1,068,231
2007-07-02 AGN Allergan Inc Sale 20,106 57.54 1,156,838
2007-05-31 AGN Allergan Inc Option Ex 4,479 106.26 475,938
2007-05-31 AGN Allergan Inc Sale 4,479 125.00 559,875
2006-11-20 AGN Allergan Inc Option Ex 56,000 62.52 3,501,120
2006-11-20 AGN Allergan Inc Sale 56,000 120.00 6,720,000
2006-03-29 AGN Allergan Inc Option Ex 52,108 52.26 2,723,164
2006-03-29 AGN Allergan Inc Sale 25,214 108.43 2,734,029
2006-03-29 AGN Allergan Inc Option Ex 22,714 64.79 1,471,640
2006-03-29 AGN Allergan Inc Sale 19,778 108.47 2,145,359
2006-03-29 AGN Allergan Inc Option Ex 18,578 33.39 620,319
2006-03-29 AGN Allergan Inc Sale 48,408 108.50 5,252,122

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ball F Michael (Chief Executive Officer of Hospira Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.